Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.

Liver international : official journal of the International Association for the Study of the Liver(2023)

引用 0|浏览7
暂无评分
摘要
For NAFLD patients, CAP exhibited good performance in monitoring clinically relevant decline of hepatic steatosis in MRI-PDFF. With the cutoffs of -46 dB/m or -15%, ΔCAP is useful in excluding clinical relevant outcome achievement.
更多
查看译文
关键词
controlled attenuation parameter (CAP), magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF), non-alcoholic fatty liver disease (NAFLD)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要